FDA finalizes penalties for trial sponsors, but critics say they fall short

FDA finalizes penalties for trial sponsors, but critics say they fall short

FDA efforts penalize trial sponsors that fail to provide data doesn’t go far enough, critics say

By ED SILVERMAN

ALEX HOGAN/STAT

“This seems to severely limit when and where the FDA plans to actually try and enforce the law,” said Nicholas DeVito of the University of Oxford's EBM Lab.

READ MORE